Login / Signup

Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.

Carolina Pantuzza RamosEmily Oliveira LopesAmanda Nadia DinizFrancisco Carlos Faria LobatoEduardo Garcia VilelaRodrigo Otavio Silveira Silva
Published in: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (2020)
Clostridioides (Clostridium) difficile is responsible for most cases of nosocomial diarrhea and, despite the high prevalence of the disease worldwide, the best laboratory diagnostic approach to diagnose C. difficile infection (CDI) is a subject of ongoing debate. Although the use of multiple tests is recommended, the cost of these algorithms commonly exceeds the affordability in some countries. Thus, to improve CDI diagnosis in a university hospital in Brazil, this study analyzed two immunochromatographic tests and one enzyme immunoassay (ELISA) to evaluate the detection of glutamate dehydrogenase (GDH) and A/B toxins of C. difficile. Stool samples of 89 adult patients presenting nosocomial diarrhea during hospitalization were included. The toxigenic culture was used as the reference method. GDH detection by both commercial tests showed high sensitivity (100%) and specificity (92.1%). On the other hand, toxin-based methods showed a sensitivity between 19.2 and 57.7%. In conclusion, the results suggest that rapid tests for GDH detection are not only suitable for CDI diagnosis as screening tests but also as a single method.
Keyphrases
  • clostridium difficile
  • loop mediated isothermal amplification
  • escherichia coli
  • label free
  • machine learning
  • sensitive detection
  • case report
  • quantum dots
  • irritable bowel syndrome